Record Details

Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs
 
Creator Lopatriello, Stefania
Negrini, Cristina
Amoroso, Domenico
Donati, Sara
 
Subject Pharmacoeconomics; Health economics
Oral; Infusional chemotherapy; Clinical pattern; Costs
 
Description The clinical pattern of Metastatic ColoRectal Cancer patients, receiving first-line infusional 5-FU or oral capecitabine (CAP) chemotherapies, was valorized in the perspective of the Italian NHS. A cost-minimization analysis was implemented on the basis of retrospective data from 5 centers. 202 subjects: 126 receiving 5-FU-association, 10 5-FU-monotherapy; 31 CAP-association, 35 CAP-monotherapy. Therapeutic patterns differed as to chemotherapy administration resources consumption: 5-FU was administered in Day Hospital and CAP in the outpatient setting. Mean total cost/patient was in the range of € 6,841 (monotherapy-5-FU)- € 12,620 (association-5-FU) and € 2,056 (monotherapy-CAP)-€ 9,745 (association-CAP). The infusional administration route of 5-FU was the driver of costs.
 
Publisher SEEd Medical Publishers
 
Contributor
 
Date 2009-09-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/173
10.7175/fe.v10i3.173
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 10, No 3 (2009); 129-134
2240-256X
1721-6915
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/173/164
 
Coverage


 
Rights Copyright (c) 2009 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0